MedTrace Logo

A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50

NCT04192630 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 390

Last updated 2024-05-28

Study results available
· View outcomes & findings →

Summary

The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

CVisc50 OVD

Bausch + Lomb CVisc50 Cohesive OVD

DEVICE

ProVisc OVD

ProVisc OVD

PROCEDURE

Cataract Surgery

Cataract Surgery

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Anya Loncaric · B+L

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-26
Primary Completion
2022-01-31
Completion
2022-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04192630 on ClinicalTrials.gov